90 related articles for article (PubMed ID: 23541984)
1. Gamma scintigraphy in the analysis of ketoprofen behaviour from matrix tablets.
Vueba ML; Rodrigues A; Lourenço P; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Int J Pharm; 2013 May; 448(1):298-304. PubMed ID: 23541984
[TBL] [Abstract][Full Text] [Related]
2. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluations of ketoprofen extended release pellets prepared using powder layering technique in a rotary centrifugal granulator.
Pai R; Kohli K; Jain G; Srivastava B
Arch Pharm Res; 2011 Jul; 34(7):1135-42. PubMed ID: 21811920
[TBL] [Abstract][Full Text] [Related]
4. Bio-dis and the paddle dissolution apparatuses applied to the release characterization of ketoprofen from hypromellose matrices.
Ramos Pezzini B; Gomes Ferraz H
AAPS PharmSciTech; 2009; 10(3):763-71. PubMed ID: 19495988
[TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of controlled release matrices of ketoprofen and influence of different co-excipients on the release mechanism.
Wahab A; Khan GM; Akhlaq M; Khan NR; Hussain A; Khan MF; Khan H
Pharmazie; 2011 Sep; 66(9):677-83. PubMed ID: 22026123
[TBL] [Abstract][Full Text] [Related]
6. Investigating the in vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of co-excipients on drug release patterns.
Shah SU; Shah KU; Rehman A; Khan GM
Pak J Pharm Sci; 2011 Apr; 24(2):183-92. PubMed ID: 21454168
[TBL] [Abstract][Full Text] [Related]
7. Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of ketoprofen.
Gavini E; Sanna V; Juliano C; Giunchedi P
J Microencapsul; 2003; 20(2):193-201. PubMed ID: 12554374
[TBL] [Abstract][Full Text] [Related]
8. [Application of synthetic and semisynthetic polymers (Kollidon K30 and hydroxypropylmethylcellulose) as carriers of ketoprofen in solid oral prolonged-release dosage forms].
Linka W; Kot M; Kołodziejczyk M
Polim Med; 2016; 46(2):145-153. PubMed ID: 28397455
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo erosion of two different hydrophilic gel matrix tablets.
Abrahamsson B; Alpsten M; Bake B; Larsson A; Sjögren J
Eur J Pharm Biopharm; 1998 Jul; 46(1):69-75. PubMed ID: 9700024
[TBL] [Abstract][Full Text] [Related]
10. Development of microbial trigger based oral formulation of Tinidazole and its Gamma Scintigraphy Evaluation: A promising tool against anaerobic microbes associated GI problems.
Sharma BG; Kumar N; Nishad DK; Khare NK; Bhatnagar A
Eur J Pharm Sci; 2016 Jun; 89():94-104. PubMed ID: 27108116
[TBL] [Abstract][Full Text] [Related]
11. Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets.
Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Eur J Pharm Biopharm; 2004 Jul; 58(1):51-9. PubMed ID: 15207537
[TBL] [Abstract][Full Text] [Related]
12. Formulation optimization, in vitro characterization and stability studies of sustain release tablets of Ketoprofen.
Hafeez A; Razvi N; Talib N; Ghayas S; Anjum F; Bushra R
Pak J Pharm Sci; 2019 May; 32(3 (Supplementary)):1245-1251. PubMed ID: 31303597
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of ketoprofen bioavailability by formation of microsponge tablets.
Comoglu T; Savaşer A; Ozkan Y; Gönül N; Baykara T
Pharmazie; 2007 Jan; 62(1):51-4. PubMed ID: 17294814
[TBL] [Abstract][Full Text] [Related]
14. A pharmacoscintigraphic study of three time-delayed capsule formulations in healthy male volunteers.
McConville JT; Hodges LA; Jones T; Band JP; O'Mahony B; Lindsay B; Ross AC; Florence AJ; Stanley AJ; Humphrey MJ; Wilson CG; Stevens HN
J Pharm Sci; 2009 Nov; 98(11):4251-63. PubMed ID: 19387976
[TBL] [Abstract][Full Text] [Related]
15. Release of ketoprofen enantiomers from HPMC K100M matrices--diffusion studies.
Solinís MA; de la Cruz Y; Hernández RM; Gascón AR; Calvo B; Pedraz JL
Int J Pharm; 2002 Jun; 239(1-2):61-8. PubMed ID: 12052691
[TBL] [Abstract][Full Text] [Related]
16. Correlation between in vitro and in vivo erosion behaviour of erodible tablets using gamma scintigraphy.
Ghimire M; Hodges LA; Band J; Lindsay B; O'Mahony B; McInnes FJ; Mullen AB; Stevens HN
Eur J Pharm Biopharm; 2011 Jan; 77(1):148-57. PubMed ID: 20971189
[TBL] [Abstract][Full Text] [Related]
17. KINETICS STUDY ON KETOPROFEN RELEASE FROM MINI TABLETS AND MULTI-COMPARTMENT SYSTEMS.
Stawarski T; Sieradzki E; Gałecka E; Binek K
Acta Pol Pharm; 2016; 73(3):731-7. PubMed ID: 27476291
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro/in vivo evaluation of a ketoprofen orally disintegrating/sustained release tablet.
Wei Q; Yang F; Luan L
Drug Dev Ind Pharm; 2013 Jun; 39(6):928-34. PubMed ID: 22401710
[TBL] [Abstract][Full Text] [Related]
19. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
Pradhan R; Kim YI; Chang SW; Kim JO
Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
